Table 6.
The Effect of Definitive Antimicrobial Regimens Adjusted by PSM on the 30-Day Mortality of Patients with CRAB BSI
| Antimicrobial Regimen | No. of Deceased Patients/Total No. of Patients(%) | Cox Regression | |||
|---|---|---|---|---|---|
| Univariate | Multivariate | ||||
| OR(95% CI) | P | OR(95% CI) | P | ||
| Cefoperazone/sulbactam | 4/21(19.0) | Reference | – | Reference | – |
| Cefoperazone/sulbactam+Tigecycline | 6/21(28.6) | 1.643(0.463–5.827) | 0.442 | 1.784(0.497–6.409) | 0.375 |
| Cefoperazone/sulbactam | 3/9(33.3) | Reference | – | Reference | – |
| Tigecycline | 7/9(77.8) | 3.352(0.856–13.128) | 0.082 | 4.607(1.105–19.210) | 0.036 |
| Cefoperazone/sulbactam | 1/18(5.6) | Reference | – | Reference | |
| Carbapenem | 8/18(44.4) | 9.758(1.218–78.173) | 0.032 | 9.646(1.203–77.328) | 0.033 |
| Cefoperazone/sulbactam | 1/13(7.7) | Reference | – | Reference | – |
| Other regimens | 6/13(46.2) | 7.088(0.851–59.012) | 0.070 | 8.892(1.038–76.140) | 0.046 |